VedaBio

Recent Finacing

Equity

Recent Raise

$40M

VedaBio has developed the CRISPR Cascade platform, a near-instant molecular detection technology that aims to become the gold standard for molecular detection in various applications, including research tools, diagnostics, and therapeutics.